Mounjaro (tirzepatide) is an injectable medication developed by Eli Lilly for treating adults with type 2 diabetes. Recently, it has gained massive attention across Canada and worldwide because of its remarkable results in blood sugar control and weight loss. With the demand rising, many Canadians are now asking the same question: how much is Mounjaro in Canada?
Mounjaro works by activating both the GIP and GLP-1 receptors, helping control appetite and improve insulin sensitivity. Its popularity for weight management has expanded far beyond diabetes treatment, but this popularity also means high prices and limited availability in some provinces.
How Much Is Mounjaro in Canada Without Insurance?
The price of Mounjaro can vary widely across pharmacies, provinces, and dosages. As of late 2025, Mounjaro costs anywhere between CA $400 and CA $900 per month, depending on the strength and format.
Here’s a breakdown of current market estimates for those paying out of pocket:
-
2.5 mg or 5 mg doses: around CA $140 – CA $200 per vial.
-
7.5 mg or 10 mg doses: between CA $200 – CA $260 per vial.
-
12.5 mg or 15 mg doses: often CA $260 – CA $300 per vial or up to CA $800-$900 per pen in some pharmacies.
That means the average Canadian might pay CA $9,000 CA $10,000 per year if using Mounjaro long-term at higher doses without insurance coverage.
Why Prices Differ Across Canada
There are several reasons why how much is Mounjaro in Canada can vary so much from person to person:
-
Dosage strength: Higher doses naturally cost more.
-
Pen vs vial format: Pre-filled pens are more convenient but more expensive.
-
Pharmacy mark-ups: Each pharmacy sets its own retail price, influenced by province and supply.
-
Insurance coverage: Most public drug plans in Canada do not yet list Mounjaro, though some private insurers may cover it if prescribed for type 2 diabetes.
-
No generic available: Since no generic tirzepatide currently exists in Canada, prices remain high under the brand Mounjaro.
Provincial Coverage and Reimbursement Challenges
Canada’s public healthcare system means every province has its own drug coverage rules. Unfortunately, in 2025 most provincial formularies do not include Mounjaro under standard coverage, especially for weight-loss use.
For example:
-
Ontario, Alberta, and British Columbia have not yet added Mounjaro to their public plans.
-
Private insurance may reimburse partial costs only if the patient meets certain clinical criteria (e.g., proof of failed metformin therapy for diabetes).
So, when people search “how much is Mounjaro in Canada,” the honest answer often depends on whether you have private insurance without it, you’ll likely pay full retail price.
How to Save Money on Mounjaro in Canada
If you’re struggling with Mounjaro’s cost, consider these practical options:
-
Ask your doctor about lower doses. Lower strengths can be more affordable.
-
Compare different pharmacies. Online or mail-order pharmacies may offer better prices.
-
Check for manufacturer savings programs. Eli Lilly occasionally provides rebates or assistance to eligible patients.
-
Review your private insurance plan. Some insurers cover diabetes indications only knowing your eligibility can save thousands annually.
-
Monitor for generics. Once patents expire, competition will likely reduce prices dramatically.
The Hidden Costs and Value Considerations
While it’s tempting to focus solely on price, Mounjaro’s effectiveness can make it a worthwhile investment for some patients. Clinical trials have shown dramatic improvements in both glucose control and weight loss compared to older medications. However, since treatment is long-term, patients must evaluate whether paying CA $400-$900 monthly fits within their healthcare budget.
Future Outlook: Will Mounjaro Become Cheaper in Canada?
Industry experts predict that as more GLP-1 and GIP receptor drugs enter the Canadian market, Mounjaro’s price may gradually decrease. Generic or biosimilar versions could appear later in the decade, improving accessibility. Additionally, public and private insurance programs may expand coverage once Mounjaro gains full approval for weight management currently under review in several countries.
Conclusion
So, how much is Mounjaro in Canada? On average, Canadians can expect to pay between CA $400 and CA $900 per month, depending on dosage, location, and insurance coverage. The high cost remains a barrier for many patients, especially those without private plans. Still, Mounjaro’s proven effectiveness makes it a valuable option for managing type 2 diabetes and supporting weight loss.
Until generic versions arrive or coverage expands, Canadians should explore all available discounts, insurance options, and medical guidance to ensure they receive both the health benefits and the best possible value for their investment.
